Clarke P, Khan AM, Kamdar N, Seiler K, Latham-Mintus K, Peterson MD, Meade MA, Ehrlich JR. Risk of type 2 diabetes mellitus among adults aging with vision impairment: the role of the neighborhood environment. Disabil Health J. 2023 Jan;16(1):101371. doi: 10.1016/j.dhjo.2022.101371
Dattilo J, Siperstein GN, McDowell ED, Schleien SJ, Whitaker E, Block M, Spolidoro M, Bari J, Hall A. Perceptions of programming needs for inclusive leisure services. JPRA. 2019 Oct 24;37(4):70-91. doi: 10.18666/JPRA-2019-9514
Goyal RK, Tzivelekis S, Rothman KJ, Candrilli SD, Kaye JA. Time trends in utilization of G-CSF prophylaxis and risk of febrile neutropenia in a Medicare population receiving adjuvant chemotherapy for early-stage breast cancer. Support Care Cancer. 2018 Feb;26(2):539-48. doi: 10.1007/s00520-017-3863-9
Hauber AB, Mange B, Price MA, Wolin D, Bensink M, Kaye JA, Chandler D. Administration options for pegfilgrastim prophylaxis: patient and physician preferences from a cross-sectional survey. Support Care Cancer. 2018 Jan;26(1):251-60. doi: 10.1007/s00520-017-3841-2
Marion S, Tzivelekis S, Darden C, Price MA, Sherif B, Garcia J, Kaye JA, Chandler D. "Same-day" administration of pegfilgrastim following myelosuppressive chemotherapy: clinical practice and provider rationale. Support Care Cancer. 2016 Sep;24(9):3889-96. doi: 10.1007/s00520-016-3193-3